Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

94.80p
   
  • Change Today:
      0.30p
  • 52 Week High: 121.60
  • 52 Week Low: 91.40
  • Currency: UK Pounds
  • Shares Issued: 539.79m
  • Volume: 1,608,529
  • Market Cap: 511.72m
  • RiskGrade: 119

Alliance Pharma Overview

Our Vision is to be a leading international healthcare business, built around products that are clinically valuable to patients.

1 Day Chart (17-08-2022)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 1.8% 1.8%
Div Cover 3.8 3.8
Op Mrgn 13.2% 23.2%
ROCE 46.4%  
Latest F'cast
P/E 14.8 14.6
PEG 0.6 15.1
Pr/Revenue 3.1 2.7
Pr/Book 1.8  
Latest F'cast
Revenue 25.7% 16.0%
PBT 39.5% 141.7%
EPS 25.0% 1.0%
DPS 5.0% 1.4%

Alliance Pharma Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-17 101.64 28.29 5.33p 12.6 0.3 +38% 1.33p 2.0%
31-Dec-18 118.21 22.80 4.54p 14.8 n/a -15% 1.46p 2.2%
31-Dec-19 135.64 31.08 5.09p 16.5 1.4 +12% 0.54p 0.6%
31-Dec-20 129.80 13.02 5.11p 17.1 n/a 0% 1.61p 1.8%
31-Dec-21 163.21 18.16 6.39p 17.0 0.7 +25% 1.69p 1.6%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Alliance Pharma Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-22 189.36 43.89 6.45p 14.7 15.2 +1% 1.72p 1.8%
31-Dec-23 207.78 49.61 6.96p 13.6 1.7 +8% 1.81p 1.9%

Copyright © 2022 FactSet Research Systems Inc. All rights reserved.

Alliance Pharma Company Announcements

Notification of Major Holdings 17-Aug-2022 13:21 RNS
Notification of Major Holdings 17-Aug-2022 07:00 RNS
Change of Auditor 08-Aug-2022 07:00 RNS

Latest Alliance Pharma Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 94.80p
Change Today 0.30p
% Change 0.32 %
52 Week High 121.60
52 Week Low 91.40
Volume 1,608,529
Shares Issued 539.79m
Market Cap 511.72m
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
88.76% below the market average88.76% below the market average88.76% below the market average88.76% below the market average88.76% below the market average
26.32% above the sector average26.32% above the sector average26.32% above the sector average26.32% above the sector average26.32% above the sector average
Price Trend
15.99% above the market average15.99% above the market average15.99% above the market average15.99% above the market average15.99% above the market average
71.88% above the sector average71.88% above the sector average71.88% above the sector average71.88% above the sector average71.88% above the sector average
Income
53.01% below the market average53.01% below the market average53.01% below the market average53.01% below the market average53.01% below the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
Growth
5.15% above the market average5.15% above the market average5.15% above the market average5.15% above the market average5.15% above the market average
17.95% above the sector average17.95% above the sector average17.95% above the sector average17.95% above the sector average17.95% above the sector average

What The Brokers Say

Strong Buy 5
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 5
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 09-Jun-22 16-Dec-21
Paid 07-Jul-22 07-Jan-22
Amount 1.13p 0.56p

Trades for 17-Aug-2022

Time Volume / Share Price
17:11 1,143 @ 94.70p
16:38 35,000 @ 94.74p
16:38 35,000 @ 94.74p
16:35 1,987 @ 94.80p
16:35 83,787 @ 94.80p

Alliance Pharma Key Personnel

CEO Peter Butterfield
CFO Andrew Franklin

Top of Page